Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (X) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 14.20 | 14.20 | 10.20 | 10.20 | 10.20 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | -60.40 | -48.83 | -48.22 | -51.15 | -45.36 |
| Loan funds | |||||
| Secured loans | 67.99 | 52.13 | 2.85 | 1.00 | 0.99 |
| Unsecured loans | - | - | 45.04 | 24.94 | 20.37 |
| Total | 21.79 | 17.50 | 9.87 | -15.01 | -13.80 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 46.43 | 36.44 | 31.18 | 25.10 | 24.58 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 18.52 | 16.46 | 14.87 | 13.68 | 12.68 |
| Net block | 27.91 | 19.98 | 16.31 | 11.42 | 11.90 |
| Capital work-in-progress | - | 0.34 | 0.65 | - | - |
| Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Net current assets | |||||
| Current assets, loans & advances | 26.30 | 10.81 | 16.85 | 7.15 | 9.21 |
| Less : current liabilities & provisions | 32.47 | 13.68 | 24.00 | 33.63 | 34.96 |
| Total net current assets | -6.17 | -2.87 | -7.15 | -26.48 | -25.75 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 21.79 | 17.50 | 9.87 | -15.01 | -13.80 |
| Notes: | |||||
| Book value of unquoted investments | 0.05 | 0.05 | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | 1.20 | 1.20 | 1.20 | 1.20 |
| Number of equity sharesoutstanding (Lacs) | 142.01 | 142.01 | 102.01 | 102.01 | 102.01 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis